A new biodegradable device for treating peripheral arterial disease
Biocarpet: The Next Generation Endovascular Device for Peripheral Arterial Disease
This study is testing a new device called the Biocarpet, which is designed to help people with peripheral arterial disease (PAD) by providing a gentle support for their blood vessels, with the hope of improving their treatment results and reducing complications.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10914995 on NIH RePORTER |
What this research studies
This research focuses on developing the Biocarpet, a novel endovascular device designed to treat peripheral arterial disease (PAD). The Biocarpet is a fully biodegradable sheet that conforms to the patient's vascular anatomy, aiming to reduce the mechanical stress on blood vessels during deployment. By addressing the common issues of restenosis and device failure associated with current treatments like balloon angioplasty and stents, this approach seeks to improve long-term outcomes for patients with PAD. The research involves testing the Biocarpet's effectiveness and durability in a clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with peripheral arterial disease, particularly those experiencing advanced symptoms requiring intervention.
Not a fit: Patients with mild PAD or those who are not candidates for endovascular interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and durable treatments for patients suffering from peripheral arterial disease, potentially reducing the need for amputations.
How similar studies have performed: While the Biocarpet represents a novel approach, similar biodegradable devices have shown promise in other vascular applications, indicating potential for success in this area.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Vande Geest, Jonathan Pieter — University of Pittsburgh at Pittsburgh
- Study coordinator: Vande Geest, Jonathan Pieter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.